Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
The value of lab test utilization management—and the ASCP’s latest best practice recommendations for effective test utilization
Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch
How artificial intelligence and machine learning tools stand to benefit clinical labs throughout the genomics pathway